No other disease consistently exhibited elevated SUMO 2/3 immunoreactivity to the same degree as FXTAS, but several other brain samples from patients exhibiting neurodegenerative disease did exhibit higher than normal levels of SUMO 2/3, including FTD, HD, and PSP. Here, SUMO3 is linked to supranuclear palsy, progressive, 1.